Skip to main content
Equibles
MMSI logo

MMSI · Merit Medical Systems Inc · Metrics

Track MMSI — free

Use MMSI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MMSI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$84.31 -1.93 (-2.24%) At close · Nov 2 Q1 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.17B
Shares
59.92M
Volume · Nov 2 1.2M Avg daily vol (3M) 762.45K

MMSI metrics

109 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$84.31
Market cap
$5.17B

Price action

20 metrics
Price change (1W)
-7.6%
Price change (30D)
-1.0%
Price change (3M)
+1.4%
Price change (6M)
+39.1%
Price change (YTD)
-2.2%
Price change (1Y)
+3.9%
Trailing year
Price change (5Y)
+28.2%
52-week high
$94.20
52-week low
$60.31
Change from 52-week high
-8.5%
Change from 52-week low
+43.0%
Annualized volatility
30.5%
Annualized volatility (3M)
25.6%
Beta
0.5
RSI (14D)
41.3
Price vs SMA 50
-2.7%
Price vs SMA 200
+12.1%
Avg volume (3M)
777,790
Relative volume
2.3
Average dollar volume
$68.90M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
59.92M

Valuation

12 metrics
P / E (TTM)
32.3
Trailing earnings · reciprocal yield 3.1%
PEG ratio
0.6
EV / revenue
3.4×
reciprocal yield 29.8%
EV / EBITDA
15.8×
reciprocal yield 6.3%
EV / EBIT
24.8×
reciprocal yield 4.0%
P / sales
3.2×
reciprocal yield 31.2%
P / book
3.0
reciprocal yield 33.8%
FCF yield
3.9%
TTM · current market cap
Buyback yield
—
P / FCF
25.4
reciprocal yield 3.9%
P / operating cash flow
18.9
reciprocal yield 5.3%
Earnings yield
3.1%

Historical valuation

8 metrics
P / E historical average (3Y)
41.6×
reciprocal yield 2.4%
P / E historical average (5Y)
50.5×
reciprocal yield 2.0%
EV / revenue historical average (3Y)
3.8×
reciprocal yield 26.6%
EV / revenue historical average (5Y)
3.7×
reciprocal yield 27.2%
EV / EBIT historical average (3Y)
32.5×
reciprocal yield 3.1%
EV / EBIT historical average (5Y)
40.9×
reciprocal yield 2.4%
EV / EBITDA historical average (3Y)
18.7×
reciprocal yield 5.4%
EV / EBITDA historical average (5Y)
21.1×
reciprocal yield 4.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-29

Profitability

9 metrics
Gross margin
49.4%
Operating margin
13.5%
Trailing 12 months
Net margin
9.9%
Gross profit (TTM)
$795.95M
Operating profit (TTM)
$217.52M
Net income (TTM)
$160.12M
Trailing 12 months
Diluted EPS (TTM)
$2.67
FCF margin
12.6%
Effective tax rate
24.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$26.80
Gross profit per diluted share (TTM)
$13.24
Operating profit per diluted share (TTM)
$3.62
EBITDA per diluted share (TTM)
$5.70
Net income per diluted share (TTM)
$2.66
Operating cash flow per diluted share (TTM)
$4.55
Free cash flow per diluted share (TTM)
$3.39
Capital expenditures per diluted share (TTM)
$1.17
R&D per diluted share (TTM)
$1.61
Stock compensation per diluted share (TTM)
$0.75
Book value per share
$26.66

Growth

11 metrics
Revenue growth YoY
+8.4%
Year over year
Net income growth YoY
+52.4%
Revenue (TTM)
$1.61B
Trailing 12 months
EPS growth YoY
+52.2%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+9.6%
Revenue CAGR (5Y)
+9.5%
EPS CAGR (3Y)
+18.2%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+46.0%
FCF CAGR (5Y)
+12.6%

Quality

14 metrics
Return on equity
9.2%
Return on assets
5.5%
Debt / equity
0.4
Current ratio
4.5
EBITDA (TTM)
$342.49M
Free cash flow (TTM)
$203.59M
Quick ratio
3.0
Interest coverage
6.7
Net debt / EBITDA
0.7
Return on invested capital
8.3%
Trailing 12 months
Net cash
−$233.85M
Latest balance sheet
Cash & equivalents
$503.55M
Total assets
$2.92B
Total debt
$737.40M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$273.74M
Capital expenditures (TTM)
$70.15M
R&D (TTM)
$96.93M
SG&A (TTM)
$481.78M
Stock compensation (TTM)
$45.39M
R&D / revenue
6.0%
Stock compensation / revenue
2.8%

Ownership (13F)

9 metrics
13F filers
409
13F filer change QoQ
+4
Institutional ownership
106.0%
Conviction holders (share of 13F filers)
0.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+4.6%
Holder tenure
15.5
Price vs estimated holder cost
-12.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
27.7%

Short interest

3 metrics
Short interest
6.3%
Latest settlement · 6.0 days to cover
Days to cover
6.0d
Short-squeeze score
77 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$678,360
Insider-sentiment score
40 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 856982 CUSIP 589889104 13F (30d) 153 filings 132 filers Visit website Investor relations